| 2013 ESH/ESC Guidelines for the management of arterial hypertension G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ... Arterial Hypertension 17 (2), 69-168, 2013 | 22355* | 2013 |
| 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and … B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ... European heart journal 39 (33), 3021-3104, 2018 | 4252 | 2018 |
| 2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension Guidelines Committee Journal of hypertension 21 (6), 1011-1053, 2003 | 3636 | 2003 |
| Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. B Williams, PS Lacy, SM Thom, K Cruickshank, A Stanton, D Collier, ... Circulation 113 (9), 1213-1225, 2006 | 2983 | 2006 |
| 2016 ESC/EAS guidelines for the management of dyslipidaemias AL Catapano, I Graham, G De Backer, O Wiklund, MJ Chapman, H Drexel, ... European heart journal 37 (39), 2999-3058, 2016 | 2682* | 2016 |
| Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV B Williams, NR Poulter, MJ Brown, M Davis, GT McInnes, JF Potter, ... Journal of human hypertension 18 (3), 139-185, 2004 | 1254 | 2004 |
| Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1· 25 million people E Rapsomaniki, A Timmis, J George, M Pujades-Rodriguez, AD Shah, ... The Lancet 383 (9932), 1899-1911, 2014 | 1064 | 2014 |
| Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials HO Dickinson, JM Mason, DJ Nicolson, F Campbell, FR Beyer, JV Cook, ... Journal of hypertension 24 (2), 215-233, 2006 | 949 | 2006 |
| British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary B Williams, NR Poulter, MJ Brown, M Davis, GT McInnes, JF Potter, ... Bmj 328 (7440), 634-640, 2004 | 929 | 2004 |
| 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, pre-diabetes, and … F Cosentino, PJ Grant, V Aboyans, CJ Bailey, A Ceriello, V Delgado, ... European heart journal 41 (2), 255-323, 2020 | 883 | 2020 |
| Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes T Ninomiya, V Perkovic, BE De Galan, S Zoungas, A Pillai, M Jardine, ... Journal of the American Society of Nephrology 20 (8), 1813-1821, 2009 | 862 | 2009 |
| Guidelines for management of hypertension: report of the third working party of the British Hypertension Society LE Ramsay, B Williams, GD Johnston, GA MacGregor, L Poston, JF Potter, ... Journal of human hypertension 13 (9), 569-592, 1999 | 778 | 1999 |
| Central blood pressure measurements and antihypertensive therapy: a consensus document E Agabiti-Rosei, G Mancia, MF O’Rourke, MJ Roman, ME Safar, ... Hypertension 50 (1), 154-160, 2007 | 737 | 2007 |
| Essential hypertension FH Messerli, B Williams, E Ritz The Lancet 370 (9587), 591-603, 2007 | 718 | 2007 |
| JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice BC Society, BH Society, UK Diabetes, PCC Society, Stroke Association Heart (British Cardiac Society) 91 (Suppl 5), v1-v52, 2005 | 708 | 2005 |
| Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial B Williams, TM MacDonald, S Morant, DJ Webb, P Sever, G McInnes, ... The Lancet 386 (10008), 2059-2068, 2015 | 650 | 2015 |
| Management of hypertension: summary of NICE guidance T Krause, K Lovibond, M Caulfield, T McCormack, B Williams Bmj 343, 2011 | 642 | 2011 |
| 2018 ESC guidelines for the management of cardiovascular diseases during pregnancy: the task force for the management of cardiovascular diseases during pregnancy of the … V Regitz-Zagrosek, JW Roos-Hesselink, J Bauersachs, ... European heart journal 39 (34), 3165-3241, 2018 | 603 | 2018 |
| Follow-up of blood-pressure lowering and glucose control in type 2 diabetes S Zoungas, J Chalmers, B Neal, L Billot, Q Li, Y Hirakawa, H Arima, ... New England Journal of Medicine 371 (15), 1392-1406, 2014 | 584 | 2014 |
| Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial RJ McManus, J Mant, EP Bray, R Holder, MI Jones, S Greenfield, ... The Lancet 376 (9736), 163-172, 2010 | 578 | 2010 |
peter lacyUniversity College LondonEmail verificata su ucl.ac.uk
